USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | -61.26 | - | - | -2.71 Million | 1.81 Million |
Net Income | - | -778.74 | - | - | 376 Thousand | 1.11 Million |
Depreciation & Amortization | - | - | - | - | 62 Thousand | 54 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 212.49 | - | - | -3.36 Million | 760 Thousand |
Other non-cash items | - | 504.99 | - | - | 3.72 Million | -762 Thousand |
Investing Cash Flow | - | 120.43 | - | - | -1.6 Million | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | -1.5 Million | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 120.43 | - | - | -100 Thousand | - |
Financing Cash Flow | - | - | - | - | 5.52 Million | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 5.52 Million | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | -53.10 | - | - | -21 Thousand | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | -3.01 | - | - | -3.37 Million | 760 Thousand |
Other working capital | - | 268.59 | - | - | 30 Thousand | - |
Cash at beginning of period | - | - | - | 125 Thousand | 321 Thousand | 556 Thousand |
Cash at end of period | - | 59.17 | - | 125 Thousand | 125 Thousand | 321 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 59.17 | - | - | -196 Thousand | -235 Thousand |
Free Cash Flow | - | -61.26 | - | - | -2.71 Million | 1.81 Million |
Breakdown | 2022 FY | 2022 Q2 | 2022 Q1 | 2021 FY | 2020 FY | 2019 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | 225.67 | 225.67 | -778.74 | - | - |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -221.60 | -221.60 | 212.49 | - | - |
Other non-cash items | - | -4.08 | -4.08 | 504.99 | - | - |
Investing Cash Flow | - | - | - | 120.43 | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | 120.43 | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | -53.10 | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | -3.01 | - | - |
Other working capital | - | -221.60 | -221.60 | 268.59 | - | - |
Cash at beginning of period | - | - | - | - | - | 125 Thousand |
Cash at end of period | - | - | - | 59.17 | - | 125 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | 59.17 | - | - |
Free Cash Flow | - | - | - | -61.26 | - | - |
ACHR-WT
NNE
DR
CGEN
300425
SYNGENE